BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18565885)

  • 1. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
    Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
    Ng K; Wolpin BM; Meyerhardt JA; Wu K; Chan AT; Hollis BW; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
    Br J Cancer; 2009 Sep; 101(6):916-23. PubMed ID: 19690551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
    Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
    Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
    Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
    J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
    J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
    Fedirko V; Riboli E; Tjønneland A; Ferrari P; Olsen A; Bueno-de-Mesquita HB; van Duijnhoven FJ; Norat T; Jansen EH; Dahm CC; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Lukanova A; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Benetou V; Trichopoulos D; Grioni S; Vineis P; Panico S; Palli D; Tumino R; Siersema PD; Peeters PH; Skeie G; Brustad M; Chirlaque MD; Barricarte A; Ramón Quirós J; Sánchez MJ; Dorronsoro M; Bonet C; Palmqvist R; Hallmans G; Key TJ; Crowe F; Khaw KT; Wareham N; Romieu I; McKay J; Wark PA; Romaguera D; Jenab M
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):582-93. PubMed ID: 22278364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
    Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT
    Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer.
    Yuan C; Song M; Zhang Y; Wolpin BM; Meyerhardt JA; Ogino S; Hollis BW; Chan AT; Fuchs CS; Wu K; Wang M; Smith-Warner SA; Giovannucci EL; Ng K
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2323-2331. PubMed ID: 32917664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer.
    Je Y; Lee JE; Ma J; Zhang X; Cho E; Rosner B; Selhub J; Fuchs CS; Meyerhardt J; Giovannucci E
    Cancer Causes Control; 2013 Apr; 24(4):719-29. PubMed ID: 23340905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer.
    Chong DQ; Mehta RS; Song M; Kedrin D; Meyerhardt JA; Ng K; Wu K; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1138-45. PubMed ID: 26382604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.
    Gibbs DC; Bostick RM; McCullough ML; Um CY; Flanders WD; Jenab M; Weiderpass E; Gylling B; Gram IT; Heath AK; Colorado-Yohar S; Dahm CC; Bueno-de-Mesquita B; Perez-Cornago A; Trichopoulou A; Tumino R; Kühn T; Fedirko V
    Int J Cancer; 2020 Nov; 147(10):2725-2734. PubMed ID: 32391587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer.
    Hiraki LT; Joshi AD; Ng K; Fuchs CS; Ma J; Hazra A; Peters U; Karlson EW; Giovannucci E; Kraft P; Chan AT
    PLoS One; 2014; 9(3):e92212. PubMed ID: 24670869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
    Yang L; Chen H; Zhao M; Peng P
    Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
    Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
    Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
    Fuchs MA; Yuan C; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Innocenti F; Warren RS; Bertagnolli MM; Ogino S; Giovannucci EL; Horvath E; Meyerhardt JA; Ng K
    Ann Oncol; 2017 Jun; 28(6):1359-1367. PubMed ID: 28327908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer.
    Zgaga L; Theodoratou E; Farrington SM; Din FV; Ooi LY; Glodzik D; Johnston S; Tenesa A; Campbell H; Dunlop MG
    J Clin Oncol; 2014 Aug; 32(23):2430-9. PubMed ID: 25002714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
    Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
    PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.